| ¡¡ |  |
 |
¡¡ |
1. What is China Pharma¡¯s business? |
| Since 1993, Helpson, China Pharma¡¯s subsidiary, has developed to a specialty bio-pharmaceutical company with Scalable GMP certified manufacturing facilities in Haikou, China, with eight different production lines with extra capacity, which develops, manufactures and markets Western and Chinese medicines. The Company has a wide distribution network, a professional marketing team, and a strong R&D ability. The Company has a portfolio of therapeutics that primarily targets CNS, cardiovascular, cerebrovascular, wound recovery, and infectious diseases. It has a robust portfolio, a segmented market, a promising pipeline with high margin which addresses large patient populations, and a highly professional and experienced management team.
|
2. What is China Pharma¡¯s ticker symbol, exchange, and CUSIP? |
| Our ticker symbol is CPHI and our common stock trades on the OTC: BB. Our CUSIP is 0001106644. |
3. When was China Pharma founded? |
| China Pharma¡¯s subsidiary, Helpson was established in 1993 as equity foreign-invested joint venture as defined by China¡¯s laws on foreign invested companies. |
4. How many China Pharma shares are outstanding? |
| As of September 30, 2007, there were 37,228,938 shares outstanding. |
5. Has China Pharma ever split its stock? |
| On June 16, 2005, all of the outstanding shares of Helpson were acquired by Onny, a development stage enterprise. On October 19, 2005, Onny was reorganized as a wholly-owned subsidiary of the Company. The reorganization was accomplished through the exchange of 29,700 shares of Onny common stock for 20,555,329 shares of the Company's common stock and for the commitment of the Company to issue an additional 4,723,056 shares upon amending its articles of incorporation. The exchange of shares was a 851-for-1 exchange ratio. In addition, the prior Onny preferred shareholders exchanged their 10,000 shares of Onny common stock for 6,944,611 shares of the Company's common stock for a 694-for-1 exchange ratio. Additionally, the prior Onny preferred shareholders converted their preferred stock into Onny common shares. The reorganization of Onny into the Company was recognized as a stock split of the common stock of Onny and the effective issuance by Onny of 2,500,060 shares of common stock to the Company's pre-reorganization shareholders and the assumption of $4,473 of liabilities. The reverse acquisition of the Company was recognized as a non-monetary exchange. |
6. When is the next earnings release? |
| China Pharma¡¯s reported quarterly earnings releases are tentatively scheduled to be released six weeks following a quarter-end and 90 days following our fiscal year-end. All earnings releases are posted on our website. |
7. What is China Pharma¡¯s fiscal year and corresponding quarter-end dates? |
| China Pharma operates on a calendar year, which runs from January 1 - December 31. Quarter-ends are: March 31, June 30, September 30, and December 31. |
8. How can I get on an e-mail list to receive all press releases? |
| To receive all press releases and other financial reports via e-mail and to automatically receive email alerts for the information categories that interest you, please click on Email Alerts and submit your email address. |
9. Who is China Pharma¡¯s Independent Certified Public Accountants? |
| China Pharma¡¯s accounting firm is Hansen, Barnett & Maxwell, PC (5 Triad Center, Suite 750, 55 North 300 West, Salt Lake City, UT 84180-1128) |
10. Who is China Pharma's outside legal counsel? |
| China Pharma¡¯s outside counsel is King and Wood LLP (650 Page Mill Road, Palo Alto, CA 94304) |
11. What is China Pharma¡¯s worldwide number of employees? |
| China Pharma had 150 world-wide employees as of September 30, 3007. |
12. What industries does China Pharma serve? |
| China Pharma serves the hospital and retail/pharmacy sectors of the Chinese pharmaceutical market. |
13. Does China Pharma have any subsidiaries? |
| China Pharma has one main subsidiary: Helpson Bio-pharmaceutical Co., Ltd |
Corporate Profile |
| Conference Calls |
 |
| FAQ Email Alerts IR Contact |
